Page 175 - ESHRE2019

Donors are replaceable, partners are not
Is this a valid argument?
No, in the sense that screening a partner need not result in changing partner, but can also result in PGD.
Where PGD is available and affordable, the argument is not convincing.
11
Product liability
Sonja Pedersen, mother of a donor child affected with neurofibromatosis: “They earn a lot of money doing this. And one has a responsibility to make sure that the product, so to speak, is all right.“ (BBC News, 25 September 2012)
Is this a valid argument?
To a certain extent, yes. However:
It is impossible to rule out all genetic risk factors and costs should not be prohibitively high to ensure access.
Responsibility can also translate into providing more risk information.
12
169
PRECONGRESS COURSE 01 I VIENNA, AUSTRIA – 23 JUNE 2019 173